论文部分内容阅读
目的:观察不同剂型利巴韦林治疗小儿手足口病的疗效与不良反应差异。方法:手足口病患儿100例按入院先后顺序分为观察组与对照组各50例,分别采用利巴韦林气雾剂和注射剂静滴给药,疗程均为7 d。治疗结束后比较两组疗效与安全性。结果:观察组的痊愈率(82.0%)和总有效率(92.0%)均明显高于对照组(P<0.05);观察组患儿的总肠道病毒、EV71病毒率也高于对照组(P<0.05)。观察组不良反应发生率明显低于对照组(P<0.05)。结论:利巴韦林气雾剂治疗小儿手足口病较静脉注射更安全有效。
Objective: To observe the curative effect and side effects of different dosage forms of ribavirin in the treatment of hand-foot-mouth disease in children. Methods: 100 cases of hand-foot-mouth disease were divided into observation group and control group according to the order of hospital admission, and 50 cases were treated with ribavirin aerosol and injection respectively. The course of treatment was 7 days. After treatment, the efficacy and safety of the two groups were compared. Results: The cure rate (82.0%) and total effective rate (92.0%) in the observation group were significantly higher than those in the control group (P <0.05). The total enterovirus and EV71 virus rates in the observation group were also higher than those in the control group P <0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P <0.05). Conclusion: Ribavirin aerosol is more safe and effective in the treatment of HFMD in children than intravenous injection.